This event will take place twice on August 14th, 2023
First schedule: 1pm EDT / 7pm CEST
Second schedule: 7pm EDT / 1am CEST (+1)
This expert webinar is designed to improve knowledge around the recommendations and monitoring requirements for exercise and pregnancy in patients with hypertrophic cardiomyopathy (HCM). It assists primary healthcare professionals to:
- better understand the benefits and risks for HCM patients participating in sports and exercise
- describe the overall risk factors and complications during pregnancy, childbirth and the postpartum period in women with HCM
This webinar is 60 minutes duration.
Family/general/internal medicine physicians, nurse practitioners, registered nurses, clinical nurse specialists, physician assistants, pediatricians, pediatric nurses.
This activity is supported by educational grant funding from Bristol Myers Squibb and Cytokinetics. Learners may participate in this educational activity free of charge.
- Overview of exercise physiology in HCM
- Overall benefits versus risk of exercise for patients with HCM
- Current guideline versus expert recommendations for exercise in HCM
- Overview of pregnancy in HCM
- What are the complication risks and when?
- Management and monitoring strategies throughout pregnancy and the postpartum period
- Q&A and closing remarks
By the end of this activity, attendees will be able to:
- outline exercise physiology and potential effects in HCM
- describe the current guideline recommendations for physical activity for HCM patients
- summarize the risk factors and complications during pregnancy and the postpartum period in HCM patients
- recount the monitoring needs for an HCM patient throughout each pregnancy trimester and in particular, any high-risk scenario
This activity will provide continuing education (CE) credits for physicians, physician assistants, nurses and nurse practitioners.
Dr Martin Maron, MD, Director of the Hypertrophic Cardiomyopathy Center, Lahey Hospital, Burlington, Massachusetts, US, has received financial compensation for consulting for Cytokinetics, Imbria, Edgewise Therapeutics, and received research grants from IRhythm Technologies.
AffinityCE staff, PCM Scientific staff, as well as planners and reviewers have no relevant financial interests to disclose.
Mitigation of relevant financial relationships
AffinityCE adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.